Stockreport

Beam Therapeutics Inc. (BEAM) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]

Beam Therapeutics Inc.  (BEAM) 
PDF This compares to loss of $1.22 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -3.54 [Read more]